Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

CRMD stock hub

CorMedix Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

CRMDis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

621.3M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

CRMD

In the news

Latest news · CRMD

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E15.5

P25 12.3P50 18.4P75 33.1

Trailing P/E3.9

P25 14.9P50 23.2P75 38.5

ROE66.6

P25 -105.6P50 -46.5P75 -3.1

ROIC36.7

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All CRMD market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

243

Groups with data

Currency

USD

Showing 243 of 243 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001410098
Company name	CorMedix Inc.
Country	United States
Country code	US
Cusip	21900C308
Employees	191
Employees Change	126%
Employees Change Percent	193.8
Enterprise value	$611.3M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2010-03-25
Isin	US21900C3088
Last refreshed	2026-05-10
Market cap	$621.3M
Market cap category	Small-Cap
Price	$7.92
Price currency	USD
Rev Per Employee	1,631,984.29x
Sector	Healthcare
Sic	2834
Symbol	CRMD
Website	https://cormedix.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	26.09%
EV Earnings	3.77x
EV Sales Forward	1.94x
EV/EBIT	3.81x
EV/EBITDA	3.5x
EV/FCF	3.54x
EV/Sales	1.96x
FCF yield	27.81%
Forward P/E	15.49x
P/B ratio	1.55x
P/E ratio	3.88x
P/S ratio	1.99x
PS Forward	1.97x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	51.44%
EBITDA Margin	56.11%
FCF margin	55.43%
Gross margin	92.91%
Gross Profit	$289.6M
Gross Profit Growth	616.21%
Gross Profit Growth Q	290.36%
Gross Profit Growth3 Y	1,574.59%
Gross Profit Growth5 Y	509.67%
Net Income	$162.1M
Net Income Growth Q	4.13%
Net Income Growth Quarters	6%
Net Income Growth Years	2%
Pretax Margin	48.13%
Profit Margin	52.31%
Profit Per Employee	$848,518
Profitable Years	1
ROA	21.21
Roa5y	-19.1
ROCE	24.6
ROE	66.56
Roe5y	-26.75
ROIC	36.73

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-7.08%
Cagr15y	-1.34%
Cagr1y	-32.21%
Cagr3y	16.96%
Cagr5y	-1.43%
EPS Growth Q	-28.28
EPS Growth Years	2
Revenue Growth	617.03x
Revenue Growth Q	312.1x
Revenue Growth Quarters	3x
Revenue Growth Years	1x
Revenue Growth3 Y	1,582.83x
Revenue Growth5 Y	319.75x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.66
Assets	$826.1M
Cash	$148.5M
Current Assets	$367.1M
Current Liabilities	$174.3M
Debt	$148.9M
Debt EBITDA	$0.85
Debt Equity	$0.37
Debt FCF	$0.86
Equity	$405.3M
Interest Coverage	57.64
Liabilities	$420.8M
Long Term Assets	$459.1M
Long Term Liabilities	$246.6M
Net Cash	$10M
Net Cash By Market Cap	$1.61
Net Cash Growth	-80.49%
Net Debt EBITDA	$-0.06
Net Debt Equity	$-0.02
Net Debt FCF	$-0.06
Tangible Book Value	$-3.8M
Tangible Book Value Per Share	$-0.05
WACC	10.18

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.11
Inventory Turnover	1.18
Net Working Capital	$45.7M
Quick ratio	1.83
Working Capital	$192.8M
Working Capital Turnover	$2.28

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-36.41%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-52%
1Y total return	-32.19%
200-day SMA	9.76
3Y total return	60%
50-day SMA	7.07
50-day SMA vs 200-day SMA	50under200
5Y total return	-6.93%
All Time High	52
All Time High Change	-84.77%
All Time High Date	2015-04-01
All Time Low	0.73
All Time Low Change	987.17%
All Time Low Date	2012-06-15
ATR	0.3
Beta	1.46
Beta1y	0.24
Beta2y	1.52
Ch YTD	-31.9
High	8.15
High52	17.43
High52 Date	2025-06-23
High52ch	-54.56%
Low	7.82
Low52	6.13
Low52 Date	2026-03-06
Low52ch	29.31%
Ma50ch	11.99%
Premarket Change Percent	0
Premarket Price	$7.92
Premarket Volume	1,096
Price vs 200-day SMA	-18.87%
RSI	60.9
RSI Monthly	48.54
RSI Weekly	46.51
Sharpe ratio	-0.26x
Sortino ratio	-0.27
Total Return	-36.41%
Tr YTD	-31.9
Tr15y	-18.35%
Tr1m	10.46%
Tr1w	1.67%
Tr3m	2.99%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	6
Analyst Count Top	1
Analyst Price Target Top	$15
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$0.33
Earnings EPS Estimate Growth	10
Earnings Revenue Estimate	105,936,288x
Earnings Revenue Estimate Growth	171.08x
Operating Income	$160.3M
Operating Income Growth Q	435.9
Operating margin	51.44
Price target	$14.83
Price Target Change	$87.25
Price Target Change Top	$89.39

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	67,521,600%
Float Percent	86.08%
Net Borrowing	149,812,000
Shares Insiders	7.17%
Shares Institutions	46.67%
Shares Out	78,442,290
Shares Qo Q	8.94%
Shares Yo Y	36.41%
Short Float	23.28%
Short Ratio	13.34
Short Shares	20.04

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$159M
Average Volume	975,159.65x
Bv Per Share	5.11
CAPEX	$-2.3M
Ch10y	-52
Ch15y	-18.35
Ch1m	10.46
Ch1w	1.67
Ch1y	-32.19
Ch3m	2.99
Ch3y	60
Ch5y	-6.93
Ch6m	-26.39
Change	0%
Change From Open	-1.37
Close	7.92
Days Gap	1.39
Depreciation Amortization	14,549,000
Dollar Volume	6,802,543.4
Earnings Date	2026-05-14
Earnings Time	bmo
EBIT	$160.3M
EBITDA	$174.9M
EPS	$2.04
F Score	5
FCF	$172.8M
FCF EV Yield	28.27x
FCF Per Share	$2.2
Financing CF	238,453,000
Fiscal Year End	December
Founded	2,006
Goodwill	30,002,000
Graham Number	15.32038
Graham Upside	93.44
Income Tax	$-13M
Investing CF	-308,430,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-03-05
Last Report Date	2025-12-31
Last Split Date	2019-03-26
Last Split Type	Reverse
Last10k Filing Date	2026-03-05
Ma150	8.92
Ma150ch	-11.2%
Ma20	7.57
Ma20ch	4.66%
Net CF	105,069,000
Next Earnings Date	2026-05-14
Open	8.03
Optionable	Yes
P FCF Ratio	3.6
P OCF Ratio	3.55
Position In Range	30.3
Post Close	7.92
Postmarket Change Percent	1.01
Postmarket Price	$8
Ppne	9,925,000
Pre Close	7.92
Price Date	2026-05-08
Price EBITDA	$3.55
Relative Volume	0.88x
Revenue	311,709,000x
SBC By Revenue	4.44x
Share Based Comp	13,832,000
Tax By Revenue	-4.18x
Tr6m	-26.39%
Us State	New Jersey
Volume	858,907
Z Score	2.13

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does CRMD pay a dividend?

Capital-return profile for this ticker.

Performance

CRMD stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns CRMD?

Insider, institutional, and short-interest positioning.

Institutional ownership

+46.7%

Float: +86.1% of shares outstanding

Insider ownership

+7.2%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

CRMD momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

60.9

Neutral momentum band

Price vs 200-day MA

-18.9%

50/200-day relationship not available

Beta (5Y)

1.46

More volatile than the market

Sharpe ratio

-0.26

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About CRMD

Hub-level FAQ points readers to the deeper analysis pages.

What is the current CRMD stock rating?

CorMedix Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full CRMD analysis?

The full report lives at /stocks/CRMD/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for CRMD?

The latest report frames CRMD around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the CRMD page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.